Richard Fosbeary

Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia

Eliza Yankova, Wesley Blackaby, Mark R. Albertella et al. · Nature · 2021 · 1.2K citations · Full text

Hematological Malignancy, Tumor Biology, Medicine +9

IRAK-4 inhibitors. Part III: A series of imidazo[1,2-a]pyridines

George M. Buckley, Richard Fosbeary, Joanne L. Fraser et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 51 citations · Full text

Medicinal Chemistry, Bioorganic Chemistry, Irak-4 Inhibitors +8

Pharmacological Inhibition of the RNA m6a Writer METTL3 As a Novel Therapeutic Strategy for Acute Myeloid Leukemia

Konstantinos Tzelepis, Étienne De Braekeleer, Eliza Yankova et al. · Blood · 2019 · 25 citations

Synthesis and structure–activity relationship of aminopyrimidine IKK2 inhibitors

Alistair H.A. Bingham, Richard Davenport, Richard Fosbeary et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 21 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Aminopyrimidine Ikk2 Inhibitors +6

A Fragment-Based Approach to Identifying<i>S</i>-Adenosyl-<scp>l</scp>-methionine -Competitive Inhibitors of Catechol<i>O</i>-Methyl Transferase (COMT).

Marion Lanier, Géza Ambrus, Derek C. Cole et al. · Journal of Medicinal Chemistry · 2014 · 12 citations · Full text